Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine deliveryOH, Yu-Kyoung; KIM, Jong-Pil; TAE SUN HWANG et al.Vaccine. 2001, Vol 19, Num 31, pp 4519-4525, issn 0264-410XConference Paper

DNA vaccines against enteric infectionsHERRMANN, John E.Vaccine. 2006, Vol 24, Num 18, pp 3705-3708, issn 0264-410X, 4 p.Conference Paper

DNA vaccines : Recent developments and future possibilitiesLIU, Margaret A; WARREN, Britta; KARLSSON HEDESTAM, Gunilla B et al.Human gene therapy. 2006, Vol 17, Num 11, pp 1051-1061, issn 1043-0342, 11 p.Article

Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccineOKONKOWSKI, J; KIZER-BENTLEY, L; LISTNER, K et al.Biotechnology progress. 2005, Vol 21, Num 4, pp 1038-1047, issn 8756-7938, 10 p.Article

Influenza vaccines generated by reverse geneticsSUBBARAO, K; KATZ, J. M.Current Topics in Microbiology and Immunology. 2004, Vol 283, pp 313-342, issn 0070-217X, 30 p.Article

Old and new vaccine approachesARNON, Ruth; BEN-YEDIDIA, Tamar.International immunopharmacology. 2003, Vol 3, Num 8, pp 1195-1204, issn 1567-5769, 10 p.Article

Chemical adjuvants for plasmid DNA vaccinesGREENLAND, John R; LETVIN, Norman L.Vaccine. 2007, Vol 25, Num 19, pp 3731-3741, issn 0264-410X, 11 p.Article

DNA vaccines for cancer tooMIN YU; FINN, Olivera J.Cancer immunology and immunotherapy. 2006, Vol 55, Num 2, pp 119-130, issn 0340-7004, 12 p.Article

Protection of flounder against hirame rhabdovirus (HIRRV) with a DNA vaccine containing the glycoprotein geneJI YEON SEO; KIM, Ki-Hong; KIM, Sung-Gu et al.Vaccine. 2006, Vol 24, Num 7, pp 1009-1015, issn 0264-410X, 7 p.Article

Protective immunity against α-cobratoxin following a single administration of a genetic vaccine encoding a non-toxic cobratoxin variantPERGOLIZZI, Robert G; DRAGOS, Rachel; ROPPER, Alexander E et al.Human gene therapy. 2005, Vol 16, Num 3, pp 292-298, issn 1043-0342, 7 p.Article

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccinesTUDOR, Daniela; DUBUQUOY, Catherine; GABORIAU, Valérie et al.Vaccine. 2005, Vol 23, Num 10, pp 1258-1264, issn 0264-410X, 7 p.Article

New approaches in immunotherapy: allergen vaccination with immunostimulatory DNACRETICOS, Peter Socrates; CHEN, Yi-Hsing; SCHROEDER, John T et al.Immunology and allergy clinics of North America. 2004, Vol 24, Num 4, pp v-vi, issn 0889-8561, 13 p.Article

Spermine compaction is an efficient and economical method of producing vaccination-grade DNAMOURICH, Dan V; MUNKS, Michael W; MURPHY, Jason C et al.Journal of immunological methods. 2003, Vol 274, Num 1-2, pp 257-264, issn 0022-1759, 8 p.Article

DNA vaccination can protect Cyprinus Carpio against spring viraemia of carp virusKANELLOS, Theofanis; SYLVESTER, Ian D; D'MELLO, Felicity et al.Vaccine. 2006, Vol 24, Num 23, pp 4927-4933, issn 0264-410X, 7 p.Article

In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDVHAYGREEN, E. A; KAISER, P; BURGESS, S. C et al.Vaccine. 2006, Vol 24, Num 23, pp 4951-4961, issn 0264-410X, 11 p.Article

Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype OYANMIN LI; AGGARWAL, Neeraj; TAKAMATSU, Haru-H et al.Vaccine. 2006, Vol 24, Num 21, pp 4602-4606, issn 0264-410X, 5 p.Article

Engineering of needle-free physical methods to target epidermal cells for DNA vaccinationKENDALL, Mark.Vaccine. 2006, Vol 24, Num 21, pp 4651-4656, issn 0264-410X, 6 p.Article

Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m³ fermentation scale for an influenza pandemicHOARE, Mike; SUSANA LEVY, M; BRACEWELL, Daniel G et al.Biotechnology progress. 2005, Vol 21, Num 6, pp 1577-1592, issn 8756-7938, 16 p.Article

Gene therapy meets vaccine developmentCOLLINS, Mary K; CERUNDOLO, Vincenzo.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 12, pp 623-626, issn 0167-7799, 4 p.Article

Bacteriophage lambda is a highly stable DNA vaccine delivery vehicleJEPSON, Catherine D; MARCH, John B.Vaccine. 2004, Vol 22, Num 19, pp 2413-2419, issn 0264-410X, 7 p.Conference Paper

Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategyLAW, Mansun; CARDOSO, Rosa M. F; WILSON, Ian A et al.Journal of virology. 2007, Vol 81, Num 8, pp 4272-4285, issn 0022-538X, 14 p.Article

Poly-L-lysine-coated nanoparticles : A potent delivery system to enhance DNA vaccine efficacyMINIGO, Gabriela; SCHOLZEN, Anja; TANG, Choon K et al.Vaccine. 2007, Vol 25, Num 7, pp 1316-1327, issn 0264-410X, 12 p.Article

Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. CommentarySCHWARTZ, Benjamin; GELLIN, Bruce; LIPATOV, Aleksandr S et al.The Journal of infectious diseases. 2005, Vol 191, Num 8, pp 1207-1209, issn 0022-1899, 8 p.Article

DNA vaccines & adjuvantsSTEVENSON, Freda K.Immunological reviews. 2004, Vol 199, issn 0105-2896, 278 p.Serial Issue

Low effectiveness of DNA vaccination against HER-2/neu in ageingPROVINCIALI, Mauro; SMORLESI, Arianna; DONNINI, Alessia et al.Vaccine. 2003, Vol 21, Num 9-10, pp 843-848, issn 0264-410X, 6 p.Conference Paper